» Articles » PMID: 33995864

Coexistence of Osteomalacia in Osteoporotic Hip Fractures in More Than 50 Years Age Group

Overview
Journal Indian J Orthop
Publisher Springer Nature
Specialty Orthopedics
Date 2021 May 17
PMID 33995864
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Osteomalacia is a hitherto common orthopaedic condition and is commonly coexists with osteoporosis. However, the identification of osteomalacia always slips under the radar and more emphasis is given to diagnosis and management of osteoporosis. Identification of osteomalacia is equally relevant as management of the osteoporotic fractures is different with or without osteomalacia.

Methods: This was a prospective study design that included patients 50 years or above of either sex presented with proximal femur fractures. Osteoporosis was identified by DEXA scan of hip and lumbar spine. Metabolic tests including serum calcium, phosphorus, ALP and vitamin D levels were done. Histopathological diagnosis of osteomalacia was performed on bony tissues that were taken during surgery from a site adjacent to the fracture and histological examination was performed on non-decalcified paraffin sections using special stains.

Results: A total of 45 patients was included in study. Mean age was 68.7 years (53-85 years). Abnormal values of serum calcium, phosphorus, ALP, vitamin D were noted in 44.4%, 22.2%, 53.3% and 48.9% patients, respectively. On histopathology, 73.17% patients showed osteomalacia. No significant correlation was found between serum biochemical markers and histopathology except with serum Vitamin D ( value - 0.004).

Conclusion: The majority of patients with osteoporotic hip fractures had coexisting osteomalacia. Abnormal biochemical values were not significantly associated with osteomalacia. Hence, histopathology remains the gold standard for the diagnosis of osteomalacia. Further research is needed to identify a biomarker that may enable the clinician to diagnosis and treat osteomalacia well in time.

Citing Articles

Mechanism of miRNA-31 Regulating Wnt/β-catenin Signaling Pathway by Targeting Satb2 in the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Ouyang X, Li S, Ding Y, Xin F, Liu M J Musculoskelet Neuronal Interact. 2023; 23(3):346-354.

PMID: 37654220 PMC: 10483816.


Osteomalacia Prevalence, Biochemical Profile, and Histology in Patients with Low-Energy Hip Fractures Over the Age of 45.

Mirghaderi P, Mortezaei A, Parry J, Salimi M, Mirghaderi R, Moharrami A Calcif Tissue Int. 2023; 113(3):257-265.

PMID: 37326840 DOI: 10.1007/s00223-023-01103-1.

References
1.
Khadgawat R, Brar K, Brar K, Gahlo M, Yadav C, Malhotra R . High prevalence of vitamin D deficiency in Asian-Indian patients with fragility hip fracture: a pilot study. J Assoc Physicians India. 2011; 58:539-42. View

2.
Negri A, Bogado C, Zanchetta J . Bone densitometry in a patient with hypophosphatemic osteomalacia. J Bone Miner Metab. 2004; 22(5):514-7. DOI: 10.1007/s00774-004-0516-0. View

3.
Priemel M, von Domarus C, Klatte T, Kessler S, Schlie J, Meier S . Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2009; 25(2):305-12. DOI: 10.1359/jbmr.090728. View

4.
Goswami R, Gupta N, Goswami D, Marwaha R, Tandon N, Kochupillai N . Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000; 72(2):472-5. DOI: 10.1093/ajcn/72.2.472. View

5.
Hordon L, Peacock M . Osteomalacia and osteoporosis in femoral neck fracture. Bone Miner. 1990; 11(2):247-59. DOI: 10.1016/0169-6009(90)90063-l. View